Aurora Cannabis (ACB) Financials: History & Chart

Aurora Cannabis Inc.(ACB)

Drug Manufacturers - Specialty & Generic · Edmonton, AB

$4.46+0.54 (+13.78%)

Delayed quote: Oct 5, 2026, 4:00 PM EDT

About Aurora Cannabis Inc.

Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.

Edmonton, AB

1,028 employees

www.auroramj.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Miguel Martin

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	208.45M	47.58M	27.40M	68.59M	64.88M	64.78M	62.91M	61.29M	59.95M
Cost of Goods Sold	141.04M	50.41M	14.29M	34.64M	41.70M	6.76M	47.69M	6.40M	28.79M
Gross Profit	67.41M	-2.83M	13.10M	33.95M	23.18M	58.02M	15.22M	54.89M	31.16M
Gross Profit Margin	32.3%	-5.9%	47.8%	49.5%	35.7%	89.6%	24.2%	89.6%	52.0%
Total Operating Expenses	128.54M	30.58M	31.20M	30.45M	36.30M	30.95M	36.34M	29.28M	32.93M
Research & Development	4.09M	1.78M	709K	949K	649K	682K	545K	646K	721K
Selling, General & Administrative	121.43M	28.80M	29.88M	29.18M	33.58M	28.04M	33.70M	26.53M	29.73M
Operating Income (EBIT)	-61.13M	-33.41M	-18.10M	3.50M	-13.12M	27.07M	-21.12M	25.61M	-1.77M
Operating Margin	-29.3%	-70.2%	-66.1%	5.1%	-20.2%	41.8%	-33.6%	41.8%	-2.9%
Income Before Tax (EBT)	-29.21M	-2.56M	8.23M	-1.15M	-33.73M	23.55M	-13.89M	22.28M	446K
Interest Income	3.67M	874K	750K	721K	1.33M	1.45M	1.80M	1.81M	2.19M
Interest Expense	3.45M	327K	N/A	1.53M	1.60M	1.30M	1.81M	1.35M	1.58M
Other Income/Expense	31.92M	30.85M	26.33M	-4.65M	-20.61M	-3.52M	7.23M	-3.33M	2.21M
Net Income	-79.48M	-2.84M	-41.01M	1.33M	-36.96M	23.26M	-17.06M	22.01M	-8.90M
Income Tax Expense	1.78M	284K	-3.07M	119K	4.44M	618K	1.38M	584K	-792K
Net Profit Margin	-38.1%	-6.0%	-149.7%	1.9%	-57.0%	35.9%	-27.1%	35.9%	-14.8%
EBITDA	N/A	-30.61M	N/A	8.15M	-8.64M	31.06M	-16.98M	29.38M	2.24M
EBITDA Margin	N/A	-64.3%	N/A	11.9%	-13.3%	47.9%	-27.0%	47.9%	3.7%
Depreciation & Amortization	1.68M	2.79M	-10.24M	4.65M	4.48M	3.99M	4.14M	3.77M	4.01M
EPS Basic	-1.39	-0.05	-0.71	0.02	-0.65	0.43	-0.31	0.40	-0.16
EPS Diluted	-1.39	-0.05	-0.71	0.02	-0.65	0.42	-0.31	0.40	-0.16
Weighted Average Basic Shares	61.68M	61.68M	57.47M	56.70M	54.88M	54.88M	54.88M	54.88M	54.68M
Weighted Average Diluted Shares	61.68M	61.68M	57.47M	57.32M	55.75M	55.75M	55.75M	55.75M	56.32M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	03/31/2026	03/31/2025	03/31/2024	03/31/2023	06/30/2022	06/30/2021	06/30/2020	06/30/2019
Revenue	230.48M	238.53M	199.88M	165.48M	171.86M	197.70M	197.90M	187.57M
Cost of Goods Sold	132.24M	108.18M	102.66M	154.55M	155.38M	215.08M	212.58M	78.76M
Gross Profit	98.24M	130.36M	97.22M	10.93M	16.48M	-17.38M	-14.68M	108.81M
Gross Profit Margin	42.6%	54.6%	48.6%	6.6%	9.6%	-8.8%	-7.4%	58.0%
Total Operating Expenses	131.79M	126.92M	131.57M	164.13M	196.19M	210.60M	328.36M	351.95M
Research & Development	2.89M	2.55M	2.64M	4.27M	8.07M	9.23M	19.17M	11.29M
Selling, General & Administrative	119.49M	115.67M	116.02M	126.05M	146.75M	157.09M	254.64M	279.12M
Operating Income (EBIT)	-33.55M	3.44M	-34.35M	-153.20M	-179.71M	-227.98M	-343.04M	-243.14M
Operating Margin	-14.6%	1.4%	-17.2%	-92.6%	-104.6%	-115.3%	-173.3%	-129.6%
Income Before Tax (EBT)	-40.64M	14.16M	-44.08M	-579.47M	-1.34B	-564.11M	-2.46B	-252.59M
Interest Income	4.20M	7.99M	9.48M	14.05M	3.50M	4.63M	4.35M	2.81M
Interest Expense	1.30M	5.85M	10.49M	29.18M	55.76M	53.55M	56.06M	30.11M
Other Income/Expense	-7.09M	10.72M	-9.72M	-426.27M	-1.16B	-336.13M	-2.12B	-9.45M
Net Income	-87.54M	1.11M	-51.27M	-603.81M	-1.35B	-559.13M	-2.42B	-224.22M
Income Tax Expense	1.51M	3.21M	-410K	12.23M	-1.66M	-5.10M	-60.57M	-22.85M
Net Profit Margin	-38.0%	0.5%	-25.6%	-364.9%	-785.8%	-282.8%	-1221.7%	-119.5%
EBITDA	-30.80M	19.10M	-9.90M	-114.31M	-106.99M	-148.92M	-258.55M	-175.72M
EBITDA Margin	-13.4%	8.0%	-5.0%	-69.1%	-62.3%	-75.3%	-130.7%	-93.7%
Depreciation & Amortization	2.74M	15.67M	24.46M	38.88M	72.72M	79.06M	84.49M	67.42M
EPS Basic	-1.55	0.02	-0.95	N/A	-62.06	-32.99	-245.93	-28.00
EPS Diluted	-1.54	0.02	-0.95	N/A	-62.06	-32.99	-245.93	-28.00
Weighted Average Basic Shares	56.71M	54.88M	51.26M	32.27M	21.49M	16.91M	9.68M	8.01M
Weighted Average Diluted Shares	57.30M	55.75M	51.26M	32.27M	21.49M	16.91M	9.68M	8.01M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.